CD44 and colorectal carcinoma: Another study, which investigated the expression of CD24, CD44 and CD133 in 523 tissue microarrays from CRC patients by IHC, found CD24, CD44 and CD133 expression in 51%, 96% and 25% of the cases examined respectively.